Asset Details
Do you wish to reserve the book?
Prenatal maternal COVID-19 vaccination and pregnancy outcomes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Prenatal maternal COVID-19 vaccination and pregnancy outcomes
Do you wish to request the book?
Prenatal maternal COVID-19 vaccination and pregnancy outcomes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Prenatal maternal COVID-19 vaccination and pregnancy outcomes
2021
Overview
•Although not tested on pregnant women, prenatal COVID-19 vaccination is recommended.•It is critical to address the effects of prenatal vaccination on pregnancy outcomes.•Pregnant women are less adherent with the recommendations.•Prenatal COVID-19 vaccination is not associated with adverse pregnancy outcomes.•Current results may help pregnant women make informed consent regarding vaccination.
Prenatal maternal physiological changes may cause severe COVID-19 among pregnant women. The Pfizer-BioNTech COVID-19 vaccine (BNT162b2 mRNA) has been shown to be highly effective and it is recommended for individuals aged ≥16 years, including pregnant women, although the vaccine has not been tested on the latter.
To study the association between prenatal Pfizer-BioNTech COVID-19 vaccination, pregnancy course and outcomes.
A retrospective cohort study was performed, including all women who delivered between January and June 2021 at Soroka University Medical Center, the largest birth center in Israel. Excluded were women diagnosed with COVID-19 in the past, multiple gestations or unknown vaccination status. Pregnancy, delivery and newborn complications were compared between women who received 1 or 2-dose vaccines during pregnancy and unvaccinated women. Multivariable models were used to adjust for background characteristics.
A total of 4,399 women participated in this study, 913 (20.8%) of which were vaccinated during pregnancy. All vaccinations occurred during second or third trimesters. As compared to the unvaccinated women, vaccinated women were older, more likely to conceive following fertility treatments, to have sufficient prenatal care, and of higher socioeconomic position. In both crude and multivariable analyses, no differences were found between the groups in pregnancy, delivery and newborn complications, including gestational age at delivery, incidence of small for gestational age and newborn respiratory complications.
Prenatal maternal COVID-19 vaccine has no adverse effects on pregnancy course and outcomes. These findings may help pregnant women and health care providers to make informed decision regarding vaccination.
